J BIOPHARM STAT 潤(rùn)色咨詢

Journal of Biopharmaceutical Statistics

出版年份:1991 年文章數(shù):1401 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:Bimonthly 自引率:14.4% 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為100.00%)
自引率
14.4 %
年文章數(shù)
1401
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3620)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1455次)
作者需知
暫無(wú)數(shù)據(jù)
偏重的研究方向
暫無(wú)數(shù)據(jù)
期刊簡(jiǎn)介
稿件收錄要求
This rapid publication periodical discusses quality applications of statistics in biopharmaceutical research and development and expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers drug, device, and biological research and development drug screening and drug design assessment of pharmacological activity pharmaceutical formulation and scale-up preclinical safety assessment bioavailability, bioequivalence, and pharmacokinetics phase I, II, and III clinical development premarket approval assessment of clinical safety postmarketing surveillance manufacturing and quality control technical operations regulatory issues.